This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research and Innovation for Global Health Transformation - Call 4 Stage 1 Application Form Guidance for Applicants

 

Contents

How to apply to RIGHT Call 4

Closing date:

Intent to Submit: Wednesday 10 February 2021 at 1pm UK time

RIGHT Call 4 Stage 1 Application and PPDA Application: Wednesday 10 March 2021 at 1pm UK time

 

Complete mandatory Intent to Submit form


Applicants for RIGHT Call 4 must submit an online mandatory Intent to Submit form by 10 February 2021 at 13:00 UK time. The form can be accessed here on the NIHR website.

After submitting your Intent to Submit form, applicants should not wait for a response from NIHR and should continue to submit their RIGHT Call 4 Stage 1 application via the NIHR-CCF’s Research Management System.

The Intent to Submit form is to aid the review process of the RIGHT Call 4 Stage 1 applications. No feedback will be provided on the Intent to Submit form andno applications are rejected at this stage.

If you have any queries, you can contact the NIHR RIGHT Global Health team on ccf-globalhealth@nihr.ac.uk or +44 (0)20 8843 8080.

 

Complete NIHR RIGHT Call 4 Stage 1 application

You must complete an online application via the CCF Research Management System (RMS). The closing date for applications is Wednesday, 10 March 2021 at 1pm UK time.

  • Applications will not be accepted if submitted after the exact closing date and time, the system will automatically prevent this from happening.
  • It is the applicants’ responsibility to allow sufficient time to submit an application.
  • Applicants must contact the NIHR RIGHT Global Health team by emailing ccf-globalhealth@nihr.ac.uk or calling +44 (0)20 8843 8080 immediately if they think there is a system problem, whilst attempting to continue with their submission.

ORCiD: It is mandatory for all applicants to register for an ORCiD identifier and to include this in their RMS user profile.

A word template of the Stage 1 application form is available on the NIHR website for reference only.

SECTION 1: APPLICATION SUMMARY INFORMATION

Proposal and Partnership Development Award reference number

INTERNAL USE ONLY. Provide your Proposal and Partnership Development Award application reference number. You can search using either the NIHR reference number (given when you have submitted your PPDA application) or pre-submission reference number (given when you have created a new application).

Contracting organisation

Provide details of the organisation that will be the contractor (i.e. the organisation who will sign the contract with the DHSC) if the programme is funded. If your organisation does not appear on the list, please contact the NIHR Central Commissioning Facility.

Research title

The programme title should state clearly and concisely the proposed research. Any abbreviations should be spelled out in full. Titles should be no more than 15 words.

Research type

Select the appropriate research type. If your proposed programme is predominantly primary research, please select ‘Primary Research’. If you are predominantly carrying out new analysis of existing data, select ‘Secondary Research’. If you are not sure which category to select, choose the closest match to your project as this can be adjusted later.

Proposed start date

Note this should be from 1st of the month, regardless of whether this is a working day or not. Please be realistic about your possible start date taking account of the necessary contracting and staff recruitment prior to starting your project.

Research duration (months)

Ensure you include sufficient time to complete all aspects of the research including applications approvals (where required) and the final report. This can be a maximum of 60 months.

End date

This field will automatically populate once you have entered the start date and research duration information.

Estimated research costs

Enter the total budget for research costs requested on the application form (see Finance Guidance for Applicants)

At Stage 1, applicants are required to provide a total figure for the costs on the application form and to provide further details of the cost breakdown (in particular the anticipated split of funds between the UK, ODA-eligible countries and any other international parties) by uploading a completed Finance Summary Form.

The Finance Summary Form template can be downloaded here.

Conflict checks

Please declare any conflicts or potential conflicts of interest that (Joint) Lead Applicants or your co-applicants may have in undertaking this research, including any relevant, non-personal and commercial interest that could be perceived as a conflict of interest.

Agreement

As Contracting Institution (Joint) Lead applicant, please tick the box to confirm that the information entered into the application form is correct and that you take responsibility for overall management and delivery of the research.

 

SECTION 2: CONTRACTING INSTITUTION (JOINT) LEAD APPLICANT’S CV

Some of the responses required in this section will have been pre-populated, any remaining fields must be completed.
To update your CV details, please visit the Manage My Details section in yourRMS account by selecting 'Save and Close' at the top of this screen and accessing the left hand menu toolbar.

 

SECTION 3: (JOINT) LEAD APPLICANTS RESEARCH BACKGROUND

Publication record

Provide details of a maximum of six of your most recent/relevant publications (in the last ten years) relevant to this application (using Vancouver or Harvard citation format). Please include DOI reference numbers, if needed.

Research grants held

Please select research grants held (as a named applicant) CURRENTLY or IN THE LAST 5 YEARS – as well as any additional previous grants, relevant to this application, stating who the grant is with and the amount of each grant. If no grants are held, please create a grant titled N/A in the Manage My Details section of your RMS account, then pull this through to this field. For more information about resubmission of a research/trainee funding application, or joint funding please contact the NIHR Global Health RIGHT programme team; ccf-globalhealth@nihr.ac.uk or +44 (0)20 8843 8080.

 

SECTION 4: THE RESEARCH TEAM

In the following sections you will need to individually add the names of your Joint Lead Applicant and Co-Applicants. Their roles and equitable contributions to the project should be described in this section.

Applications MUST be led by either:

  • A Principal Investigator employed by an LMIC Higher Education Institution (HEI) or Research Institution

Or

  • A Principal Investigator employed by a UK HEI or Research Institution (UK Joint Lead Applicant) to jointly lead with a Principal Investigator employed by an LMIC HEI or research institution (LMIC Joint Lead Applicant).

Please note: Where the contracting organisation is a UK institution, it is mandatory for an LMIC Joint Lead Applicant to be included on the application, with the expectation that the joint leadership/partnership is equitable. Where the contracting organisation is an LMIC institution, a UK Joint Lead Applicant is not a mandatory requirement. LMIC Lead Applicants may propose joint leadership/partnerships with a Principal Investigator from another eligible LMIC or UK institution, or lead the application without a Joint-Lead Applicant.

Co-Applicants: You can add Co-Applicants. Co-Applicants are those individuals with responsibility for the day-to-day management and delivery of the project. Co-Applicants are considered part of the project team and are expected to share responsibility for its successful delivery. All co-applicants must be registered on the Research Management System (RMS) before they can be added to the application. Please note that once you enter a Co-Applicant’s details they will receive an automated email informing them that this information has been added to your application. Therefore, we would expect Co-Applicants to have been consulted before adding their details into the RMS. Co-applicants must both confirm and approve their participation; the application cannot be submitted without doing so.

A maximum of 15 Co-applicants is permitted in addition to up to two Joint Lead Applicants.

Please note that collaborators are those who provide specific expertise on particular aspects of the project and would form the basis of your wider research team. They do not share in the responsibility for the delivery of the project.

NOTE: For contracting purposes there can only be one contracting institution for flow of funds.

Specify your (Joint) Lead Applicant (Contracting Institution) role in this research

Explain in addition to your role as (Joint) Lead Applicant, the role that you will be undertaking in the research (e.g. co-ordination and project management, analysis, methodological input etc.)

%FTE

Commitment: This refers to the percentage of your time that you will commit to this project.

Joint Lead Applicant (Non-Contracting Institution)

Please select if there is more than one Lead Applicant. Where the contracting institution is a UK institution with a UK Joint Lead Applicant, it is mandatory for an LMIC Joint Lead Applicant to be included on the application, with the expectation that the joint leadership/partnership is equitable. Please complete the name of the Joint Lead Applicant (Non-contracting Institution) contact details and other requested information.


Specify role of the Joint Lead Applicant (non-Contracting Institution) in research

Explain in addition to your role as (Joint) Lead Applicant, the role that you will be undertaking in the research, e.g. co-ordination and project management, analysis, methodological input etc.

%FTE

Commitment: This refers to the percentage of your time that you will commit to this project.

Co-Applicants

Add details of all co-applicants and their specific role in the programme. Do not include collaborators or partners, who should be mentioned (if necessary) in the ‘Research Plan’ section of the form.

Co-applicants are those individuals with responsibility for the day-to-day management and delivery of the project and can include patients, carers and service users. Co-applicants are considered part of the project team and are expected to share responsibility for its successful delivery.

Co-applicants who are community representatives, patients or carers are not obliged to complete a standard CV, but are required to provide a summary of any knowledge, skills and experience relevant to their role in the application.

We recognise and value the varied perspectives that community representatives, patients and carers bring to a project as applicants. In this section, please provide a summary of any relevant knowledge, skills and experience that you will draw upon to contribute to this project.

  • This could include information about:
  • Previous or present work (paid or unpaid) with any relevant organisations
  • Links with any relevant groups, committees, networks or organisations
  • Experience of particular health conditions, treatments, use of services - or as a member of a particular community
  • Knowledge and experience of research including previous research undertaken
  • Knowledge and experience of community and public involvement
  • Skills from any other roles that are transferable
  • Relevant qualifications, training and learning

The bullet point list above is not exhaustive. Please include anything else that is relevant to the application.

 

SECTION 5: PLAIN ENGLISH SUMMARY OF RESEARCH

A plain English summary is a clear and accessible explanation of your research.
Reviewers use this summary to inform their review of your funding application. If your application for funding is successful; the summary will be used on NIHR and other websites and should, therefore, be accessible to members of the public.

A good quality plain English summary providing an easy to read overview of your whole study will help:

  • Those carrying out the review (reviewers and board and panel members) to have a better understanding of your research proposal
  • Inform others about your research such as members of the public, health professionals, policy makers and the media
  • The research funders to publicise the research that they fund

If it is considered that your plain English summary is not clear and of a good quality then you may be required to amend it prior to final funding approval.

It is helpful to involve patients/carers/members of the public in developing a plain English summary. When writing your summary consider including the following information where appropriate:

  • Aim(s) of the research;
  • background to the research;
  • design and methods used;
  • community engagement and engagement (see below);

and

  • dissemination.

The plain English summary is not the same as a scientific abstract - please do not cut and paste this or other sections of your application form to create the plain English summary.

Further guidance on writing in plain English is available online at NIHR ‘Make it clear’ http://www.invo.org.uk/makeitclear/.

For further support and advice on writing a plain English summary, please see the INVOLVE website.

SECTION 6: RESEARCH PLAN

Using all of the headings in the order presented below, please use this section to clearly explain your proposed research. As this is the main part of your application, which will be considered by the funding committee, you should ensure that the information is accurate, succinct, clearly laid out and provides sufficient methodological detail. The overall amount of information that you can provide at this stage is limited to 3-5 pages (dependent on the type/complexity/scale of study proposed). (Limit: 2000 words).

Background and Rationale

What is the problem being addressed?

Provide a clear explanation of the problem to be addressed, the impact on patients and the community as well as health and care services in ODA-eligible country(ies) and demonstrate where the evidence gap is.
Explain how your proposed research is within the remit of the NIHR RIGHT programme and how it addresses the key aim of RIGHT Call 3 to deliver research in the area of multimorbidity in ODA-eligible country(ies).

Why is this research important in terms of improving the health and/or wellbeing of the relevant populations and healthcare services in the ODA-eligible country(ies?)

It is essential that you clearly identify the applied health and care challenges faced by the ODA-eligible country(ies) relevant to the geographic and scientific area of your research proposal. Please outline the anticipated value or contribution the research will provide.

Briefly describe:

  • The importance of the proposed research and its relevance to the priorities and needs of the ODA-eligible country(ies), including a statement of the significance of the research area (e.g. burden of disease).
  • The anticipated outputs, outcomes and impact of the proposed research on the health and wealth of patients, the community and health and care services in ODA-eligible country(ies); where possible, quantifying the potential benefits.
  • The anticipated timescale for the benefits to the ODA-eligible country(ies) resulting from the proposed research, and how this work will create an enduring impact/sustainable capacity or capability enhancement in the ODA-eligible country(ies).
Review of existing evidence - How does the existing literature support this proposal?

Explain why this research is needed now, both in terms of time and relevance. Briefly describe:

  • The need for research in this area, please include a summary of existing evidence and the rationale for the particular lines of research you plan to pursue.
  • How your proposed research would add distinct value to what is already known or in progress?
  • Work undertaken previously by the research team, which has led to the proposed programme (e.g. describe any pilot or feasibility data).

Applicants should be aware of ongoing research in this area and comment on any other research that might be deemed to overlap with the contents of the proposal. In particular, applicants are advised to use both PubMed Central and Europe PubMed Central and include references to recent material on the topic area they are applying for.

Any applications that include primary research should include reference to the existing evidence and explain how this evidence has informed the proposed research. Where a systematic review already exists that summarises the available evidence this should be referenced, as well as including references to any relevant literature published subsequent to that systematic review. Where no such systematic review exists, it is expected that the applicants will undertake an appropriate review of the currently available and relevant evidence and summarise this in their proposal.

Aims and Objectives

This section should be used to indicate the overarching aims/objectives of the research, outlining the key question(s), which the work will address and, where appropriate, the main hypothesis.

Research plan / methods

Provide an expert summary of the project plan of investigation (e.g. deliverables, methods, approach to patient and community involvement, timescales), plus any additional points required to support statements made in the previous sections, and include any key references required to justify the points made (e.g. in the use of particular outcome measures or methods of analysis). References should be provided as an attachment (see section 9: Uploads). Please clearly outline the likely risks and challenges, as well as mitigating actions, in delivering the proposed work and any ethical considerations.

Research expertise / structure of the team

Describe the skills, experience and expertise of the team that makes it well placed to carry out the proposed research. Please also list and explain the role of key collaborators or partners (i.e. those individuals who provide a substantial intellectual contribution and/or will play a role in delivering the programme of work).


Approach to creating sustainable and equitable partnerships

Include details of your approach to, and plans to, create equitable partnerships within your programme/research team. If already established, please give clear details of the involvement of individuals and organisations based in the ODA-eligible country(ies) in the development of the research proposal and in undertaking the research.

Community engagement and involvement

The NIHR has well established requirements for patient and public involvement in the research that it funds. In this global health research call, we refer throughout to ‘community engagement and involvement (CEI)’ rather than ‘patient and public involvement’. This is to emphasise the importance of involving relevant community groups and organisations from ODA-eligible country(ies) in an early and sustained manner throughout the research process.

The NIHR expects appropriate and relevant involvement of communities, patients, carers and other key stakeholders in the research it supports. It is essential to set out your approach to involving relevant community groups and organisations, patients and carers in the Stage 1 application. Consider the following issues in your response and include anything else that will give us a clear description of your approach:

  • What is the purpose of community and public involvement in your research?
  • How do you plan to identify relevant communities and organisations as potential partners from ODA-eligible country(ies)?
  • How do you plan to establish effective ways of communicating?
  • How do you plan to support and enable relevant community groups, organisations to contribute to the research as partners?
  • If you have involved relevant community groups and organisations in the development of your application, what you have changed or included as a result?

Information and resources to assist you can be found on the INVOLVE website (a detailed definition of patient and public involvement in research, briefing notes for researchers on how to involve patients and the public and an involvement cost calculator and budgeting guide).

You may also find it helpful to refer to Mesh (https://mesh.tghn.org/), a collaborative open-access web space that provides resources, encourages networking and shares good practice to bridge the gap between the research community and the general public in ODA-eligible country(ies).

Your CEI plans will be formally assessed by public reviewers, peer reviewers and the RIGHT Call 3 Funding Committee at Stage 2. However, at Stage 1, your approach to and planned CEI activities will be taken into account when assessing the proposed research.

Training and capacity strengthening in LMICs

Please detail how you intend to develop research capacity in the next generation of researchers, including via your Post-Doctoral and Doctoral appointments and the wider environment

Project management / governance (including Approach to Risk Management and Assurance / Safeguarding)

Please clearly describe programme management and governance arrangements which should represent international best practice. Sufficient resources should be allocated to manage the programme/work streams from initiation to completion.

Ethics / regulatory approvals

Outline any ethical issues that require regulatory approvals.

Success Criteria

Please set out the measurements of success you intend to use and also the key risks to delivering this research and what contingencies you will put in place to deal with them. This section should identify appropriate actions that would reduce or eliminate each risk or its impact.

SECTION 7: ODA-ELIGIBLE COUNTRIES (LOCATION OF RESEARCH)

Please select all ODA-eligible countries where the proposed research will be undertaken.

SECTION 8: ODA COMPLIANCE STATEMENT

Please provide a statement that demonstrates how the proposal meets key ODA funding requirements. It should address the following questions:

  • which country(s) on the Organisation for Economic Cooperation and Development’s (OECD) Development Assistance Committee (DAC) list of ODA-eligible countries will directly benefit;
  • how the application is directly and primarily relevant to the development challenges of those countries;

 

and

  • how the outcomes will promote the health and welfare of people in the country or countries on the DAC list.

SECTION 9: UPLOADS

Mandatory

One single-side A4 page, listing references used throughout your proposal.

Budget breakdown – at this stage, applicants are required to provide a total figure for the costs on the application form and to provide further details of the cost breakdown (in particular, the anticipated split of funds between the UK, ODA-eligible countries and any other international countries) by uploading a completed Stage 1 Financial Summary Form to the ‘Section 2: Application Summary Information’ above.

Non-mandatory

If required, an additional supporting (single side of A4) document can be submitted with your application form (e.g. a flow diagram illustrating the study design and the flow of participants, Gantt chart, pictures, diagrams etc.). If submitting a flow diagram, applicants should also describe complex interventions and controls as accurately and fully as possible within their diagram. Alternatively, you may find the EQUATOR Network website useful (www.equator-network.org).

The PDF file should be submitted along with your application form.

SECTION 10: ADMINISTRATIVE CONTACT DETAILS

Please provide the details of an administrative lead as a secondary point of contact for any queries relating to the application, should it be supported.

NOTE: This person does not need to be a co-applicant.

SECTION 11: RESEARCH AND DEVELOPMENT OFFICE CONTACT DETAILS

Please provide the contact details and job title of a person in the R&D office, so that we are able to notify them of the outcome of this application including any associated feedback.

NOTE: Please note this person does not need to be included as a co-applicant.

SECTION 12: VALIDATION SUMMARY

Please follow the next steps in order to complete your application submission process;

  • Validate all mandatory/required fields listed below (that are required to be completed/amended before submitting)
  • Check all co-applicants have completed their CV details as appropriate and review the PDF final version for any formatting issues
  • Click 'Save and Close'
  • Click the 'Submit' option (this must be completed by 1 pm (UK time), 10 March 2021)


Please note that your submission will not be considered complete until all applicants have both confirmed and approved the application and the 'Submit' button becomes available and is then used.

You will receive an automated email containing the acknowledgment that we have received your application

Checklist of information to include when submitting a NIHR RIGHT Stage 1 research application

Applicants should click the checkboxes to indicate that they have included the necessary information prior to submitting their application.

  • A good quality Plain English Summary http://www.invo.org.uk/makeitclear/ 
  • A clear explanation of the problem being addressed 
  • A clear demonstration of the need and importance of the research 
  • A review of existing literature (primary research) 
  • A clear research question/aim(s) and objectives 
  • A clear project plan summarising the study design and methods, risks and ethical considerations 
  • A clear description of team member roles and contribution 
  • A single A4 page of references (document upload), mandatory 
  • RIGHT Stage 1 Financial Summary Form (document upload), mandatory